1386 – Gastric Contractility Modulation (GCM) therapy for patients with Type 2 Diabetes with Obesity (DIAMOND™ system funding application)

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Not supported

Application details

Reason for application

New MBS item.

Service or technology in this application

Laparoscopic placement of the Implantable Pulse Generator and Charge Coil with three pairs of Ultraflex gastric leads for treatment of Type 2 Diabetes with obesity to improve glycaemic control and induce weight loss.

Type: Therapeutic

Medical condition this application addresses

Patients with Type 2 Diabetes with obesity who are inadequately controlled on standard oral glucose lowering (anti-diabetic) therapy.

Application documents

Consultation survey

PICO confirmation – Unratified draft protocol

PICO confirmation

Public summary document

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Meetings to consider this application

  • PASC meeting: 11 to 12 December 2014
  • ESC meeting: 11 to 12 June 2015
  • MSAC meeting: 30 to 31 July 2015